title: Stem-Cell Transplantation for Amyloidosis: Improving Outcomes but Not for the Faint of Heart.
authors.affiliation: Yale Cancer Center, Yale University, New Haven, CT.
authors.forename: Noffar
authors.initials: N
authors.lastname: Bar
authors.affiliation: Yale Cancer Center, Yale University, New Haven, CT.
authors.forename: Terri L
authors.initials: TL
authors.lastname: Parker
authors.affiliation: Yale Cancer Center, Yale University, New Haven, CT madhav.dhodapkar@yale.edu.
authors.forename: Madhav V
authors.initials: MV
authors.lastname: Dhodapkar
mesh_terms: D000686:Amyloidosis / Q000601:surgery*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007147:Immunoglobulin Light Chains; D008297:Male; D008558:Melphalan / Q000627:therapeutic use*; D019653:Myeloablative Agonists / Q000627:therapeutic use*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D007147:Immunoglobulin Light Chains; D019653:Myeloablative Agonists; D008558:Melphalan